| (84) |
Designated Contracting States: |
|
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
Designated Extension States: |
|
AL LT LV MK RO SI |
| (30) |
Priority: |
26.08.1998 US 97956 P
26.08.1998 GB 9818613
|
| (71) |
Applicant: GLAXO GROUP LIMITED |
|
Greenford, Middlesex UB6 ONN (GB) |
|
| (72) |
Inventors: |
|
- ANDREWS, Robert Carl,Glaxo Wellcome Inc.
Research Triangle Park, NC 27709-3398 (US)
- ANDERSEN, Marc Werner
Raleigh, NC 27612 (US)
- COWAN, David John,Glaxo Wellcome Inc.
Research Triangle Park, NC 27709-3398 (US)
- DEATON, David Norman,Glaxo Wellcome Inc.
Research Triangle Park, NC 27709-3398 (US)
- DICKERSON, Scott Howard,Glaxo Wellcome Inc.
Research Triangle Park, NC 27709-3398 (US)
- DREWRY, David Harold,Glaxo Wellcome Inc.
Research Triangle Park, NC 27709-3398 (US)
- GAUL, Michael David,Glaxo Wellcome Inc.
Research Triangle Park, NC 27709-3398 (US)
- LUZZIO, Michael Joseph,Glaxo Wellcome Inc.
Research Triangle Park, NC 27709-3398 (US)
- MARRON, Brian Edward,Glaxo Wellcome Inc.
Research Triangle Park, NC 27709-3398 (US)
- RABINOWITZ, Michael Howard,Glaxo Wellcome Inc.
Research Triangle Park, NC 27709-3398 (US)
|
| (74) |
Representative: Reed, Michael Antony et al |
|
GlaxoSmithKlineCorporate Intellectual PropertyTwo New Horizons Court
Brentford, Middlesex TW8 9EP
Brentford, Middlesex TW8 9EP (GB) |
|
